Artículos Científicos

pubmed-logo-white
DATE: 2015/02/27
People with alcohol use disorders in specialized care in eight different European countries
Alcohol Alcohol. 2015 May;50(3):310-8. doi: 10.1093/alcalc/agv009. Epub 2015 Feb 25.
AUTHORS: Rehm J, Allamani A, Aubin HJ, Della Vedova R, Elekes Z, Frick U, Jakubczyk A, Kostogianni N, Landsmane I, Manthey J, Miquel L, Paille F, Pieper L, Probst C, Scafuri F, Shield KD, Snikere S, Struzzo P, Trapencieris M, Voller F, Wittchen HU, Gual A, Wojnar M.
PMID: 25716113
MORE INFO
DATE: 2015/02/18
Acid-sensing ion channels detect moderate acidifications to induce ocular pain
Pain. 2015 Mar;156(3):483-495. doi: 10.1097/01.j.pain.0000460335.49525.17.
AUTHORS: Callejo G, Castellanos A, Castany M, Gual A, Luna C, Acosta MC, Gallar J, Giblin JP, Gasull X.
PMID: 25687542
MORE INFO
DATE: 2015/02/06
Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme
Expert Opin Drug Saf. 2015 Apr;14(4):495-504. doi: 10.1517/14740338.2015.1011619. Epub 2015 Feb 4.
AUTHORS: van den Brink W, Strang J, Gual A, Sørensen P, Jensen TJ, Mann K.
PMID: 25652768
MORE INFO
DATE: 2015/01/14
General practitioners recognizing alcohol dependence: a large cross-sectional study in 6 European countries
Ann Fam Med. 2015 Jan-Feb;13(1):28-32. doi: 10.1370/afm.1742.
AUTHORS: Rehm J, Allamani A, Della Vedova R, Elekes Z, Jakubczyk A, Landsmane I, Manthey J, Moreno-España J, Pieper L, Probst C, Snikere S, Struzzo P, Voller F, Wittchen HU, Gual A, Wojnar M.
PMID: 25583889
MORE INFO
DATE: 2015/01/02
A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocol
BMJ Open. 2014 Dec 31;4(12):e007130. doi: 10.1136/bmjopen-2014-007130.
AUTHORS: López-Pelayo H, Wallace P, Segura L, Miquel L, Díaz E, Teixidó L, Baena B, Struzzo P, Palacio-Vieira J, Casajuana C, Colom J, Gual A.
PMID: 25552616
MORE INFO
DATE: 2014/12/23
Sputtering-deposition of Ru nanoparticles onto Al2O3 modified with imidazolium ionic liquids: synthesis, characterisation and catalysis
Dalton Trans. 2015 Feb 14;44(6):2827-34. doi: 10.1039/c4dt03039g.
AUTHORS: Foppa L, Luza L, Gual A, Weibel DE, Eberhardt D, Teixeira SR, Dupont J.
PMID: 25531917
MORE INFO
DATE: 2014/12/03
Maintenance of tobacco cessation programmes in public hospitals in Catalonia, Spain
Addict Behav. 2015 Mar;42:136-9. doi: 10.1016/j.addbeh.2014.11.028. Epub 2014 Nov 26.
AUTHORS: Ballbè M, Martínez C, Saltó E, Cabezas C, Riccobene A, Valverde A, Gual A, Fernández E.
PMID: 25462661
MORE INFO
DATE: 2014/11/28
Motivational interviewing interactions and the primary health care challenges presented by smokers with low motivation to stop smoking: a conversation analysis
BMC Public Health. 2014 Nov 26;14:1225. doi: 10.1186/1471-2458-14-1225.
AUTHORS: Codern-Bové N, Pujol-Ribera E, Pla M, González-Bonilla J, Granollers S, Ballvé JL, Fanlo G, Cabezas C; ISTAPS Study Group.
PMID: 25427643
MORE INFO
DATE: 2014/11/14
Motivational interviewing for smoking cessation in a psychiatric day hospital: a feasibility study
J Dual Diagn. 2014;10(4):226-9. doi: 10.1080/15504263.2014.961851.
AUTHORS: Barrio P, Hidalgo-Mazzei D, Ilzarbe D, Fàbrega M, Moreno J, Balcells M, Mondón S, Gual A.
PMID: 25391281
MORE INFO
DATE: 2014/11/05
Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments
Psychol Med. 2015 Apr;45(6):1121-33. doi: 10.1017/S0033291714002463. Epub 2014 Nov 4.
AUTHORS: López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A.
PMID: 25366671
MORE INFO